Ultraviolet phototherapy for pruritus

Dermatologic Therapy

Volumn 18, Issue 4, 2005, Pages 344-354

  Rivard, Jennifer ^a   Lim, Henry W ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Atopic dermatitis; Dermatitis; Narrowband; Phototherapy; Polycythemia vera; Pruritus; PUVA; Therapy; Treatment; Ultraviolet; Urticaria; UVA; UVB

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BERGAPTEN; CALCIUM; CATHEPSIN G; CD4 ANTIGEN; CD8 ANTIGEN; CROTAMITON; FLUOCORTOLONE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 8; MAGNESIUM; MESSENGER RNA; METHOXSALEN; PHOSPHORUS; PLACEBO; PROTEIN BCL 2; PSORALEN; RETINOID; TUMOR NECROSIS FACTOR ALPHA;

ATOPIC DERMATITIS; BASAL CELL CARCINOMA; CHRONIC KIDNEY FAILURE; CHRONIC URTICARIA; CLINICAL TRIAL; COLD URTICARIA; DRUG DOSE REGIMEN; ERYTHEMA; FOLLICULITIS; HEADACHE; HODGKIN DISEASE; HUMAN; MACULOPAPULAR RASH; MELANOMA; NAUSEA; NONHUMAN; PHOTOAGING; PHOTOTHERAPY; POLYCYTHEMIA VERA; POMPHOLYX; PRURITUS; PSORIASIS; PUVA; RADIATION DOSE; REVIEW; SKIN CANCER; SKIN REDNESS; SOLAR URTICARIA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URTICARIA; URTICARIA PIGMENTOSA;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; PRURITUS; ULTRAVIOLET THERAPY;

EID: 29144450638     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2005.00032.x     Document Type: Review

References (124)

1. Murphy M, Carmichael AJ. Renal itch. Clin Exp Dermatol 2000: 25: 103-106.
2. Robertson KE, Mueller BA. Uremic pruritus. Am J Health-Syst Pharm 1996: 53: 2159-2170.
3. [Erratum appears in Am J Health Syst Pharm 1996: 53: 2523.]
4. Gilchrest BA, Rowe JW, Brown RS, et al. Ultraviolet phototherapy of uremic pruritus. Ann Intern Med 1979: 91: 17-21.
5. Carmichael AJ, McHugh MM, Martin AM, et al. Serological markers of renal itch in patients receiving long-term haemodialysis. Br J Dermatol 1988: 296: 1575.
6. Stahle-Backdahl M, Hagerman O, Lins L-E. The sensitivity of uremic and normal skin to histamine. Acta Derm Venereol (Stockh) 1988: 68: 230-235.
7. de Kroes S, Smeenk G. Serum vitamin A levels and pruritus in patients on hemodialysis. Dermatologica 1983: 16: 199-202.
8. Rosenthal SR. Uremic dermatitis. Arch Dermatol Syph 1931: 23: 934-945.
9. Landing BH, Wells TR, Williamson ML. Anatomy of eccrine sweat glands in children with chronic renal insufficiency and other fatal chronic diseases. Am J Pathol 1970: 54: 15-21.
10. Szepietowski J. Selected elements of the pathogenesis of pruritus in haemodialysis patients. Med Sci Monit 1996: 2: 342-347.
11. Cohen EP, Russell TJ, Garancis JC. Mast cells and calcium in severe uremic itching. Am J Med Sci 1992: 306: 360-365.
12. Szepietowski JC, Morita A, Tsuji T. Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses 2002: 58: 167-170.
13. Krutmann J, Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Invest Dermatol Sym Proc 1999: 4: 70-72.
14. Hsu MM, Yang CC. Uraemic pruritus responsive to broadband ultraviolet (UV) therapy does not readily respond to narrowband UVB therapy. Br J Dermatol 2003: 149: 888-889.
15. Blachley JD, Blankenship M, Menter A, et al. Uremic pruritus: skin divalent ion content and response to ultraviolet therapy. Am J Kidney Dis 1985: 5: 237-241.
16. Von Kobyletzki G, Pieck C, Hoffmann K, Freitag M, Altmeyer P. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol 1999: 41: 931-937.
17. Tzaneva S, Seeber A, Schwaiger M, Honigsmann H, Tanew A. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 2001: 45: 503-507.
18. Dittmar HC, Pflieger D, Schopf E, Simon JC. UVA1 phototherapy: pilot study of dose finding in acute exacerbated atopic dermatitis. Hautarzt 2001: 52: 423-427.
19. Kowalzick L, Kleinheinz A, Weichenthal M, et al. Low-dose versus medium-dose UVA1 treatment in severe atopic eczema. Acta Derm Venereol (Stockh) 1995: 75: 43-45.
20. Jekler J, Larko O. UVA solarium versus UVB phototherapy of atopic dermatitis: a paired-comparison study. Br J Dermatol 1991: 125: 569-572.
21. Jekler J, Larko O. UVB phototherapy of atopic dermatitis. Br J Dermatol 1988: 119: 697-705.
22. Reynolds NJ, Franklin V, Gray JC, et al. Narrow-band ultraviolet B and broadband ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 2001: 357: 2012-2016.
23. Legat F, Hofer A, Brabek E, et al. Narrowband UVB vs. medium-dose UVA1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003: 139: 223-224.
24. Morison WL, Parrish J, Fitzpatrick TB. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol 1978: 98: 25-30.
25. Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000: 142: 39-43.
26. Krutmann J, Diepgen TL, Luger TA, et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998: 38: 589-593.
27. Von Kobyletzki G, Pieck C, Hoxtermann S, et al. Circulating activation markers of severe atopic dermatitis following ultraviolet A1 cold light phototherapy: eosinophil cationic protein, soluble interleukin-2 receptor, and soluble interleukin-4 receptor. Br J Dermatol 1999: 140: 963-991.
28. Abeck D, Schmidt T, Fesq H, et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000: 42: 254-257.
29. Uetsu N, Horio T. Treatment of persistent severe atopic dermatitis in 113 Japanese patients with oral psoralen photochemotherapy. J Dermatol 2003: 30: 450-457.
30. Falk ES. UV-light therapies in atopic dermatitis. Photodermatol 1985: 2: 241-246.
31. Hannuksela M, Karvonen J, Husa M, et al. Ultraviolet light therapy in atopic dermatitis. Acta Derm Venereol (Stockh) 1985: 114 (suppl): 137-139.
32. Midelfart K, Stenvold S-E, Volden G. Combined UVB and UVA phototherapy of atopic eczema. Dermatologica 1985: 171: 95-98.
33. Jekler J, Larko O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study. J Am Acad Dermatol 1990: 22: 49-53.
34. Krutmann J, Schopf E. High-dose UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic eczema. Acta Derm Venereol (Stockh) 1992: 176 (suppl): 120-122.
35. Grabbe J, Welker P, Humke S, et al. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996: 107: 419-422.
36. Krutmann J. Ultraviolet A radiation-induced immunomodulation: molecular and photobiological mechanisms. Eur J Dermatol 1998: 8: 198-199.
37. Enk CD, Sredni D, Blauvelt A, Katz SI. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 1995: 154: 4851-4856.
38. Piletta PA, Wirth S, Hommel L, et al. Circulating skin-homing T cells in atopic dermatitis: selective up-regulation of HLD-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy. Arch Dermatol 1996: 132: 1171-1177.
39. Barr RM, Walker SL, Tsang W, et al. Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin. J Invest Dermatol 1999: 112: 692-698.
40. Breuckmann F, Pieck C, Kreuter A, et al. Opposing effects of UVA1 phototherapy on the expression of bcl-2 and p53 in atopic dermatitis. Arch Dermatol Res 2001: 293: 178-183.
41. Breuckmann F, von Kobyletzki G, Avermaete A, Kreuter A, Altmeyer P. Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T cell lymphoma in vivo: a comparison study. Photodermatol, Photoimmunol, Photomed 2002: 18: 217-222.
42. Breuckmann F, von Kobyletzki G, Avermaete A, et al. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy. Eur J Med Res 2002: 7: 315-322.
43. Breuckmann F, von Kobyletzki G, Avermaete A, et al. Modulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy. BMC Dermatol 2002: 2: 12.
44. Buchness MR, Lim HW, Hatcher VA, et al. Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome: treatment with ultraviolet B phototherapy. N Engl J Med 1988: 318: 1183-1186.
45. Pardo RJ, Bogaert MA, Penneys NS, et al. UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome. J Am Acad Dermatol 1992: 26: 423-428.
46. Akaraphanth R, Lim HW. HIV, UV, and immunosuppression. Photodermatol Photoimmunol Photomed 1999: 15: 28-31.
47. Ranki A, Puska P, Mattinen S, et al. Effect of PUVA on immunologic and virologic findings in HIV-infected patients. J Am Acad Dermatol 1991: 24: 404-409.
48. Gelfand JM, Rudikoff D, Lebwohl M, et al. Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study. Arch Dermatol 1998: 134: 940-945.
49. Zurlo J, Yager JD. UV-enhanced reactivation of UV-irradiated herpes virus by primary cultures of rat hepatocytes. Carcinogenesis 1984: 5: 495-500.
50. Morrey JD, Bourn SM, Bunch TD, et al. In vivo activation on human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 1991: 65: 5045-5051.
51. Valerie K, Deleres A, Brock C, et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature 1988: 333: 78-81.
52. Stanley SK, Folks TM, Fauchi A. Induction of expression of human immunodeficiency virus in chronically infected promonocytes cell line by ultraviolet irradiation. AIDS Res Hum Retroviruses 1989: 5: 375-384.
53. Breuer-McHamm J, Marshall G, Adu-Oppong A, et al. Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol 1999: 40: 48-60.
54. Breuer-McHam J, Simpson E, Dougherty I et al. Activation of HIV in human skin by ultraviolet B radiation and its inhibition by NFKB blocking agents. Photochem Photobiol 2001: 74: 805-810.
55. Menage HD, Norris PG, Hawk JL, Graves MW. The efficacy of psoralen photochemotherapy in the treatment of aquagenic pruritus. Br J Dermatol 1993: 129: 163-165.
56. Holme SA, Nastey AV. Aquagenic pruritus responding to intermittent photochemotherapy. Comment in Clin Exp Dermatol 2002; 27: 164-165.
57. Clin Exp Dermatol 2001: 26: 40-41.
58. Martinez-Escribano JA, Quecedo E, De la Cuadra J, et al. Treatment of aquagenic urticaria with PUVA and astemizole. J Am Acad Dermatol 1997: 36: 118-119.
59. Juhlin L, Malmros-Enander I. Familial polymorphous light eruption with aquagenic urticaria: successful treatment with PUVA. Photodermatology 1986: 3: 346-349.
60. Parker RK, Crowe MJ, Guin JD. Aquagenic urticaria. Cutis 1992: 50: 283-284.
61. Hannuksela M, Kokkonen EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol 1985: 65: 449-450.
62. Clark C, Pai S, Russell SC, et al. TI-01 phototherapy for chronic idiopathic urticaria: 14 years experience. Summaries of papers. Br J Dermatol 2001: 145: 136.
63. Olafsson JH, Larko O, Roupe G, et al. Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study. Arch Dermatol Res 1986: 278: 228-231.
64. Dawe RS, Ferguson I. Prolonged benefit following ultraviolet A phototherapy for solar urticaria. Br J Dermatol 1997: 137: 144-148.
65. Bernhard JD, Jaenicke K, Momtaz TK, et al. Ultraviolet A phototherapy in the prophylaxis of solar urticaria. J Am Acad Dermatol 1984: 10: 29-33.
66. Parrish JA, Jaenicke KF, Morison WL, et al. Solar urticaria: treatment with PUVA and mediator inhibitors. Br J Dermatol 1982: 106: 575-580.
67. Beissert S, Stander H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol 2000: 42: 1030-1032.
68. Godt O, Proksch E, Streit V, et al. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology 1997: 195: 35-39.
69. Schafer-Korting M, Korting HCH. Intra-individual variations of 8-methoxypsoralen plasma levels. Arch Dermatol Res 1982: 272: 1-7.
70. Kolde G, Frosch PJ, Czarnetzki BM. Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol 1984: 83: 175-178.
71. Czarnetzki BM, Rosenbach T, Kolde G, et al. Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine, and chemotactic leukotrienes. Arch Dermatol Res 1985: 277: 105-113.
72. Gobello T, Mazzanti C, Sordi D, et al. Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol 2003: 49: 679-684.
73. Baldo A, Sammarco E, Plaitano R, et al. Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythemia vera. Br J Dermatol 2002: 147: 979-981.
74. Hernandez-Nunez A, Dauden E, Cordoba S, et al. Water-induced pruritus in haematologically controlled polycythemia vera: response to phototherapy. J Dermatolog Treat 2001: 12: 107-109.
75. Jeanmougin M, Rain JD, Najean Y. Efficacy of photochemotherapy on severe pruritus in polycythemia vera. Ann Hematol 1996: 73: 91-93.
76. Samson YS, Gielczyk R, Scherschun L, et al. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photodermatol Photoimmunol Photomed 2003: 19: 164-168.
77. Reed J, George S. Pruritic folliculitis of pregnancy treated with narrowband (TL-01) ultraviolet B phototherapy. Br J Dermatol 1999: 141: 177-179.
78. Holme SA, Mills CM. Crotamiton and narrow band UVB phototherapy: novel approaches to alleviate pruritus of breast carcinoma skin infiltration. J Pain Symptom Manage 2001: 22: 803-805.
79. Kaptanoglu AF, Oskay T. Ultraviolet B treatment for pruritus in Hodgkin's lymphoma. J Eur Acad Dermatol Venereol 2003: 17: 489-490.
80. Ohe S, Danno K, Sasaki H, et al. Treatment of acquired perforating dermatosis with narrowband UVB. J Am Acad Dermatol 2004: 50: 892-894.
81. Bergasa NV, Link MJ, Keogh M, Yaroslavsky G, Rosenthal RN, McGee M. Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease. Am J Gastroenterol 2001: 96: 1563-1570.
82. Pirkhammer D, Seeber A, Honigsmann H, et al. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000: 143: 964-968.
83. Kreuter A, Jansen T, Stucker M, et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001: 26: 30-32.
84. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002: 46: 251-255.
85. Pinton PC, Capezzera R, Zane C, et al. Medium dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol 2002: 47: 410-414.
86. Elston DM, Ahmed DD, Watsky KL, et al. Hand dermatitis. J Am Acad Dermatol 2002: 47: 291-299.
87. Petering H, Breuer C, Herbst R, et al. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 2004: 50: 68-72.
88. Rosen K, Jontell M, Mobacken H, et al. Epidermal Langerhans cells in chronic eczematous dermatitis of the palms treated with PUVA and UVB. Acta Derm Venereol 1989: 69: 200-205.
89. Simons JR, Bohnen IJ, van der Valk PG. A left-right comparison of UVB phototherapy and topical photochemotherapy in bilateral chronic hand dermatitis after 6 weeks' treatment. Clin Exp Dermatol 1997: 22: 7-10.
90. Krutmann J, Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy. Invest Dermatol Symp Proc/Soc Invest Dermatol 1999: 4: 70-72.
91. Budiyanto A, Ueda M, Ueda T, et al. Formation of cyclobutane pyrimidine dimers and 8-oxo-7,8-dihydro-2′-deoxyguanosine in mouse and organ-cultured human skin by irradiation with broadband or with narrowband UVB. Photochem Photobiol 2002: 76: 397-400.
92. Krueger JG, Wolfe JT, Nabega RT, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995: 182: 2057-2068.
93. Neill WA, Halliday KE, Norval M. Differential effect of phototherapy on the activities of human natural killer cells and cytotoxic T cells. J Photochem Photobiol B 1998: 47: 129-135.
94. Lisby S, Ralfkier E, Rothlein R, et al. Intercellular adhesion molecule-1 (ICAM-1) expression correlated to inflammation. Br J Dermatol 1989: 120: 479-484.
95. Krutmann J, Khan IU, Wallis RS, et al. The cell membrane is a major locus for ultraviolet B induced alterations in accessory cells. J Clin Invest 1990a: 85: 1529-1536.
96. Krutmann J, Koeck A, Schauer E, et al. Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression. J Invest Dermatol 1990b: 95: 127-131.
97. Krutmann J, Czech W, Parlow F, et al. Ultraviolet radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition of cytokine induced ICAM-1 mRNA expression is transient, differentially restored for IFN-gamma versus TNF alpha, and followed by ICAM-1 induction via a TNF alpha-like pathway. J Invest Dermatol 1992a: 98: 923-928.
98. Norris DA, Lyons B, Middleton MH, et al. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule-1 (ICAM-1) on the surface of cultured human keratinocytes. J Invest Dermatol 1990: 95: 132-138.
99. Camacho NR, Sanchez JE, Martin RF, et al. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001: 45: 697-699.
100. Fjellner B, Hagermark O. Influence of ultraviolet light on itch and flare reactions in human skin induced by histamine and the histamine liberator compound 48/80. Acta Derm Venereol 1982: 62: 137-140.
101. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol 1995: 104: 3-6.
102. Grewe M, Duvic M, Aragane Y, et al. Lack of induction of IL-10 expression in human keratinocytes. Reply. J Invest Dermatol 1996: 106: 1330-1331.
103. Grewe M, Gyufko K, Schopf E, Krutmann J. Lesional expression of interferon gamma in atopic eczema. Lancet 1994: 343: 25-26.
104. Kumakiri M, Hashimoto K, Willis I. Biological changes of human cutaneous nerves caused by ultraviolet irradiation: an ultrastructural study. Br J Dermatol 1978: 99: 65-75.
105. Wallengren J, Sundler F. Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibers. Acta Derm Venereol 2004: 84: 111-115.
106. Konnikov N, Pincus SH, Dinarello CA. Elevated plasma interleukin-1 levels in humans following ultraviolet light therapy for psoriasis. J Invest Dermatol 1989: 92: 235-239.
107. Walters IB, Ozawa M, Cardinale I, et al. Narrowband (312 nm) UVB suppresses interferon gamma and interleukin (IL)12 and increases IL-2 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol 2003: 139: 155-161.
108. McLoone P, Man I, Yule S, et al. Whole-body UVB (TL01) or UVA-1 irradiation does not alter the levels of immunomodulatory cytokines in the serum of human volunteers. Photodermatol Photoimmunol Photomed 2004: 20: 76-80.
109. Dawe RS, Cameron H, Yule S, et al. A randomized controlled trial of narrowband ultraviolet B vs. bath psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol 2003: 148: 1194-1204.
110. Palmer RA, Friedmann PS. A comparison of six and 12 PUVA treatments in the prophylaxis of polymorphic light eruption. Clin Exp Dermatol 2004: 29: 141-143.
111. Tauscher AE, Fleischer AB, Phelps KC, et al. Psoriasis and pregnancy. J Cutan Med Surg 2002: 11: 73-75.
112. Br Photodermatol Grp. An appraisal of narrowband (TL-01) UVB phototherapy. Br Photodermatol Grp Workshop Report (April 1996). Br J Dermatol 1997: 137: 327-330.
113. Flindt-Hansen H, McFadden N, Eeg-Larsen T, et al. Effect of a new narrowband UVB lamp on photocarcinogenesis in mice. Acta Dermatol Venereol (Stockh) 1991: 71: 245-248.
114. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrowband ultraviolet B and broad spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed 1994: 10: 192-197.
115. Gibbs JK, Traynor NJ, MacKie RM, et al. The phototumorigenic potential of broadband (270-350 nm) and narrow band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol 1995: 104: 359-363.
116. Young AR. Carcinogenicity of UVB phototherapy assessed. Lancet 1995: 345: 1431-1432.
117. Pasker-de Jong PCM, Wielink G, van der Valk PGM, et al. Treatment with UVB for psoriasis and nonmelanoma skin cancer: a systematic review of the literature. Arch Dermatol 1999: 135: 834-840.
118. Laube S, George SA. Adverse effects with PUVA and UVB phototherapy. J Dermatolog Treat 2001: 12: 101-105.
119. McNeeley W, Goa KL. 5-Methoxypsoralen: a review of its effects in psoriasis and vitiligo. Drugs 1998: 56: 667-690.
120. Gach JE, Madrigal AM, Hutton JL, Charles-Holmes R. Retrospective analysis of the occurrence of internal malignancy in patients treated with PUVA between 1986 and 1999 in south Warwickshire. Clin Exp Dermatol 2004: 29: 154-155.
121. Nijsten T, Stern R. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J Am Acad Dermatol 2003: 49: 644.
122. Stern R, Bagheri S, Nichols K. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002: 47: 33.
123. Stern R. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001: 44: 755-761.
124. Lindelof B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer risk: the Swedish follow up study. Br J Dermatol 1999: 141: 108.